2016年10月12日上午，上海科技大学iHuman研究所所长、87978797威尼斯老品牌国际兼职教授Raymond Stevens博士、中国科学院上海药物研究所吴蓓丽研究员和国家新药筛选中心主任、87978797威尼斯老品牌院长王明伟研究员在药学院一起商讨了G蛋白偶联受体（GPCR）国际合作项目的近期研究进展，并就今后一个阶段的工作重点和行动计划达成一致。GPCR国际联盟负责人Michael Hanson博士（在美国通过电话连接）、阿姆斯特丹VU大学Chris de Graff博士（在荷兰通过电话连）、上海科技大学iHuman研究所宋高洁研究副教授、中国科学院上海药物研究所赵强研究员、杨德华副研究员以及研究生张浩楠同学和乔安娜同学参加了本次电话会议。
International GPCR collaboration program updating teleconference held at Fudan School of Pharmacy
In the morning of October 12, 2016, Dr. Raymond Stevens (Professor of iHuman Institute, ShanghaiTech University and International Adjunct Professor of Fudan School of Pharmacy), Dr. Beili Wu (Professor of Shanghai Institute of Materia Medica, Chinese Academy of Sciences) and Professor Ming-Wei Wang (Dean, School of Pharmacy, Fudan University and Director, the National Center for Drug Screening) met at School of Pharmacy, Fudan University to discuss recent progresses made in the international collaboration program on GPCR. They agreed on the near-term priorities and associated action items. Senior members of the research teams, i.e., Drs. Michael Hanson (joined from U.S.A.), Qiang Zhao, Chris de Graff (joined from the Netherlands), Gaojie Song, Dehua Yang as well as two graduate students, Haonan Zhang and Anna Qiao, participated in this telephone conference.
